Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UW-Madison researchers identify key to cancer cell mobility

07.11.2002


In the race to cure cancer, researchers look for roadblocks that could stop cancer in its tracks, preventing it from spreading to other parts of the body. Scientists from the University of Wisconsin-Madison may have found that blockade - an enzyme critical to the ability of cells to metastasize, a biological phenomenon by which cells migrate. The findings are published in the Nov. 7 issue of the journal Nature.



"The real, life-threatening problem with most cancers is that they migrate away from the initial site," says Richard Anderson, a UW-Madison pharmacology professor and senior author of the paper. "If we could regulate a cell’s ability to move in a selective way, we may be able to block cancer metastasis."

Researchers have identified several important factors involved in cell migration, but they continue to search for the mechanisms that regulate these key factors. Anderson and his group have found that the enzyme, noted scientifically as PIPKI?661, appears to underpin cells’ ability to move from organ to organ.


Cells can migrate through the body because they have small clusters of proteins called focal adhesions. When these clusters, located on the cell surface, respond to signals from molecules on other cells, they bind to those molecules. Once attached, the focal adhesions can pull the cell forward. Like wheels on a skateboard, these adhesions then give cells the ability to move around the body.

The key to blocking this movement, says Anderson, is inhibiting the assembly of focal adhesions. But, as he adds, these protein clusters result from the activity of several key factors, which receive their signals from a number of sources - proteins inside the cell or molecules outside it. To block focal adhesion assembly, one would have to block this other activity.

The key to doing that appears to be the enzyme, PIPKI?661, identified by Anderson and his colleagues, Kun Ling and Renee Doughman.

"What we’ve identified is an enzyme that regulates the assembly of focal adhesions," says Anderson. "Researchers have been looking for this enzyme for years."

PIPKI?661 interacts directly with two key proteins (FAK and talin) involved in focal adhesion assembly. At the same time, PIPKI?661 also generates an important second messenger (P14,5P2) that Anderson says both regulates a number of important proteins inside the cell and stimulates their ability to form focal adhesions.

Because of this enzyme’s central role in regulating the factors involved in the assembly of focal adhesions, the researchers say it provides a promising target for developing drugs to prevent cancer cells from metastasizing.

"PIPKI?661 is like one of those circular (traffic) intersections in Italy and England," says Anderson. "There are all sorts of signals feeding in and out of it, and the traffic never stops." Changing the design of the intersection, he says, could change the flow of those signals.

By blocking the activity of PIPKI?661 - the intersection of focal adhesion assembly - cancer cells could become immobile, thereby unable to migrate to other parts of the body.

"Exactly how cancer cells metastasize has been poorly understood," says Anderson. "This discovery is a real breakthrough that could really have an impact."


- Emily Carlson, (608) 262-9772, emilycarlson@wisc.edu

Richard Anderson | EurekAlert!
Further information:
http://www.wisc.edu/

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>